Blog

Categories

Companion Diagnostics (CDx)—A Central Laboratory Perspective Companion Diagnostics Alan Wookey Companion Diagnostics (CDx)—A Central Laboratory Perspective
In the June issue of Inside Precision Medicine, Alan Wookey, Vice President Companion Diagnostics and Q2 Solutions’ scientific advisor, explores the evolution of companion diagnostics (CDx) since the...
 Three key decisions cell and gene therapy trial sponsors need to make early into drug development Alan Wookey Three key decisions cell and gene therapy trial sponsors need to make early into drug development
In the rapidly growing and innovative therapeutic area, how do clinical trial sponsors effectively navigate the multitude of unique intricacies involved in cell and gene therapy development? In a...
 Cell therapy: devising a full clinical development plan Central Laboratories Alan Wookey Cell therapy: devising a full clinical development plan
Laboratory assessments — from preclinical research through post-marketing surveillance — determine whether a cell-based therapy for cancer succeeds or fails.Showcasing our IQVIA Connected...
 Elevating Effective Outcomes with Companion Diagnostics Alan Wookey Elevating Effective Outcomes with Companion Diagnostics
The successful development and commercialization of personalized medicines often necessitate use of companion diagnostics (CDx).